dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalkindlustusamet
Kiri SISSEAvalik

Kiri

Sotsiaalkindlustusamet · 9. oktoober 2024
Viit
2-10/30051-1
Registreeritud
9. oktoober 2024
Dokumendi liik
Kiri SISSE
Adressaat
VIAGENS ABREU, SA
Saabumis/saatmisviis
e-post
Funktsioon
2 Teabehaldus
Sari
2-10 ÜSS 2021-2027 projektid (endine ESF, Euroopa Komisjon)
Toimik
2-10.8
Vastutaja
Kelli Ilisson (SKA, Ohvriabi ja ennetusteenuste osakond, Ennetustalitus)
Lahendamise tähtaeg
16. oktoober 2024

Failid

  • 📎Kuvatõmmis 2024-10-17 143643.jpg
  • 📎Lisbon Addictions 2024 - - .pdf102 KB
  • 📎Proforma.pdf132 KB

Sisu (failidest)

Programme Wed 23 Oct 07:30 Arrival and registration 07:30 to 08:30 BREAK 08:30 Official opening 08:30 to 09:00 Auditorium I PLENARY SESSION 09:00 Meeting the needs of e-poster session day 1 e-short communication service users and session day 1 09:00 to 18:20 service providers 09:00 to 18:20 Plenary 1 Digital kiosks Digital kiosks 09:00 to 10:30 E-POSTER SESSION E-SHORT COMMUNICATION Auditorium I SESSION PLENARY SESSION 10:30 Coffee break 10:30 to 10:50 BREAK 10:50 Cannabis legalisation in Advances in drug Innovative health Canada and the US: treatment approaches policy variation, state of the evidence and ideas 10:50 to 12:20 10:50 to 12:20 for future research Auditorium II Auditorium III 10:50 to 12:20 ORAL PRESENTATION ORAL PRESENTATION Auditorium I SESSION SESSION MAJOR SESSION Sex, gender and diversity Advancing addiction Lives at risk: mental in drugs research: global health and substance use perspectives and 10:50 to 12:20 collaborative initiatives 10:50 to 12:20 Auditorium IV 10:50 to 12:20 Auditorium VII ORAL PRESENTATION Auditorium VI ORAL PRESENTATION SESSION SESSION ORAL PRESENTATION SESSION Prevalence of opioids and Mechanisms and Gambling: work-related, related harms outcomes in substance financial, and use prevention among criminological issues 10:50 to 12:20 youth 10:50 to 12:20 Auditorium VIII 10:50 to 12:20 Room 5B ORAL PRESENTATION Room 5A SESSION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION Building addiction Treatment of alcohol use Support for recovery workforce capacity disorder 10:50 to 12:20 10:50 to 12:20 10:50 to 12:20 Room 1.07 Room 5C Room 1.05 SHORT COMMUNICATION ORAL PRESENTATION SHORT COMMUNICATION SESSION SESSION SESSION Alcohol: policy and harm Closed session Evaluation of drug reduction consumption rooms: ECR Programme — guidance step by step 10:50 to 12:20 Scientific writing 10:50 to 12:20 Room 1.08 10:50 to 12:20 Room 1.15 SHORT COMMUNICATION Room 1.10 SESSION WORKSHOP WORKSHOP 12:20 Lunch break 12:20 to 13:20 BREAK 13:20 Enhancing access to Alcohol use in the young Neuroscience and harm reduction services cognition in community and 13:20 to 14:50 prisons: experiences of 13:20 to 14:50 translating policy into Auditorium II practice and scaling Auditorium III interventions ORAL PRESENTATION SESSION SHORT COMMUNICATION 13:20 to 14:50 SESSION Auditorium I MAJOR SESSION Legal shifts and their Drug policy and the Tobacco, mental health Impact on drug use and criminal legal system and other substance use sentencing 13:20 to 14:50 13:20 to 14:50 13:20 to 14:50 Auditorium VI Auditorium VII Auditorium IV ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION SESSION Gender and substance Substance use Neurocognitive processes use interventions in youth in behavioural addictions 13:20 to 14:50 13:20 to 14:50 13:20 to 14:50 Auditorium VIII Room 5A Room 5B ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION SESSION Learning from Africa: Alcohol use disorder: Meetings the needs of workforce development, clinical biology and women who use drugs or enhancement and epidemiology alcohol support 13:20 to 14:50 13:20 to 14:50 13:20 to 14:50 Room 1.05 Room 1.06 Room 5C SHORT COMMUNICATION SHORT COMMUNICATION ORAL PRESENTATION SESSION SESSION SESSION Challenge of measuring Methods and The peer model: the use and impact of measurement critical role of ethics in cannabinoids efficacy 13:20 to 14:50 13:20 to 14:50 13:20 to 14:50 Room 1.08 Room 1.07 Room 1.15 SHORT COMMUNICATION ORAL PRESENTATION SESSION WORKSHOP SESSION 14:50 Break 14:50 to 15:00 BREAK 15:00 Challenges in community- Alcohol use from brief The recovery journey based prevention intervention to harm reduction 15:00 to 16:30 15:00 to 16:30 15:00 to 16:30 Auditorium III Auditorium I Auditorium II ORAL PRESENTATION MAJOR SESSION SESSION ORAL PRESENTATION SESSION Infectious diseases in Measuring drug market Substance use and people who inject drugs phenomenon psychosis 15:00 to 16:30 15:00 to 16:30 15:00 to 16:30 Auditorium IV Auditorium VI Auditorium VII ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION SESSION The growing threat of Surveillance of drug- Assessment of synthetic drugs – related morbidity and behavioural addictions developments and mortality responses in North 15:00 to 16:30 America and Europe 15:00 to 16:30 Room 5B 15:00 to 16:30 Room 5A ORAL PRESENTATION Auditorium VIII ORAL PRESENTATION SESSION SESSION ORAL PRESENTATION SESSION Inequalities and needs of Responses to behavioural Quality in addictions migrant groups addictions work systems 15:00 to 16:30 15:00 to 16:30 15:00 to 16:30 Room 5C Room 1.05 Room 1.06 ORAL PRESENTATION SHORT COMMUNICATION ORAL PRESENTATION SESSION SESSION SESSION Problematic gambling Conceptualising health WAVE Cine Video contest and gaming and harms session 1: Showcasing innovative science and 15:00 to 16:30 15:00 to 16:30 services Room 1.07 Room 1.08 15:00 to 16:30 SHORT COMMUNICATION SHORT COMMUNICATION Room 1.09 SESSION SESSION VIDEO CONTEST Trauma and addiction - LEGO® SERIOUS PLAY® developing skills in the Hands-On Workshop on screening of traumatic Optimizing Workplace experiences in addiction and Well-Being for care Workers in Addiction Fields 15:00 to 16:30 15:00 to 16:30 Room 1.10 Room 1.15 WORKSHOP WORKSHOP 16:30 Coffee break 16:30 to 16:50 BREAK 16:50 The EUFAS-EAR European Strengthening quality in NPS: trends, concerns Addiction Research substance use disorders and response strategies Award treatment 16:50 to 18:20 16:50 to 18:20 16:50 to 18:20 Auditorium III Auditorium I Auditorium II ORAL PRESENTATION MAJOR SESSION ORAL PRESENTATION SESSION SESSION Drug use trends Decriminalisation and Understanding alternatives to arrest interrelationships: 16:50 to 18:20 mental health and 16:50 to 18:20 substance use Auditorium IV Auditorium VI 16:50 to 18:20 ORAL PRESENTATION SESSION ORAL PRESENTATION Auditorium VII SESSION ORAL PRESENTATION SESSION Psychedelics 1 Novel and contextual Opioid treatment 1 approaches in prevention 16:50 to 18:20 16:50 to 18:20 16:50 to 18:20 Auditorium VIII Room 5B Room 5A ORAL PRESENTATION ORAL PRESENTATION SESSION ORAL PRESENTATION SESSION SESSION Motivations for use Hepatitis C, HIV, and Opioids: trends, use and other drug related harms treatments 16:50 to 18:20 16:50 to 18:20 16:50 to 18:20 Room 5C Room 1.05 Room 1.06 ORAL PRESENTATION SESSION SHORT COMMUNICATION SHORT COMMUNICATION SESSION SESSION Capacity-building Showcasing AI and digital through competencies for workforce support the substance use workforce 16:50 to 18:20 16:50 to 18:20 Room 1.15 Room 1.10 WORKSHOP WORKSHOP 18:20 Break 18:20 to 18:30 BREAK 18:30 Why are we not doing better at reducing drug- related deaths? 18:30 to 19:30 Auditorium I BIG DEBATE Thu 24 Oct 09:00 Synthetic opioids and Expert knowledge Workshop on conducting psychedelics: new elicitation to complement drug research in prison: and enhance data Challenges and key opportunities & new collection and monitoring recommendations from challenges for clinical efforts. the European experience practice 09:00 to 10:30 09:00 to 10:30 Plenary session 2 Room 1.10 Room 1.15 09:00 to 10:30 WORKSHOP WORKSHOP Auditorium I PLENARY SESSION e-poster session day 2 e-short communication session day 2 09:00 to 18:20 09:00 to 18:20 Digital kiosks Digital kiosks E-POSTER SESSION E-SHORT COMMUNICATION SESSION 10:30 Coffee break 10:30 to 10:50 BREAK 10:50 International Predicting the future: Opioid treatment 2 collaboration to biomarkers for understand and address progression of alcohol 10:50 to 12:20 the co-occurrence of use disorder addiction with ADHD and Auditorium III autism spectrum 10:50 to 12:20 disorders ORAL PRESENTATION Auditorium II SESSION 10:50 to 12:20 ORAL PRESENTATION Auditorium I SESSION MAJOR SESSION Opioid Agonist Evidence informed drug Emerging drug harms, Treatment: novel and alcohol policy DCRs and other formulations and responses challenges 10:50 to 12:20 10:50 to 12:20 10:50 to 12:20 Auditorium VI Auditorium VII Auditorium IV ORAL PRESENTATION SESSION SHORT COMMUNICATION ORAL PRESENTATION SESSION SESSION The challenges of the Innovative methods for Young people and digital era: an understanding drug comorbidity - alcohol, interdisciplinary markets and policy gambling and mental investigation of screen health time and social media. 10:50 to 12:20 10:50 to 12:20 10:50 to 12:20 Room 5A Room 5B Auditorium VIII ORAL PRESENTATION SESSION ORAL PRESENTATION MAJOR SESSION SESSION Workers reaching Challenges, threats, and Natural language marginalised groups opportunities in addiction processing for addiction publishing today research: a practical 10:50 to 12:20 primer 10:50 to 12:20 Room 5C 10:50 to 12:20 Room 1.05 ORAL PRESENTATION Room 1.06 SESSION ORAL PRESENTATION SESSION WORKSHOP EU research funding Contemporary issues Closed session opportunities 10:50 to 12:20 ECR Programme — An 10:50 to 12:20 introduction to theory in Room 1.08 qualitative research Room 1.07 ORAL PRESENTATION 10:50 to 12:20 WORKSHOP SESSION Room 1.10 WORKSHOP Back-casting exercise on peer-support workforce development 10:50 to 12:20 Room 1.15 WORKSHOP 12:20 Lunch break 12:20 to 13:20 BREAK 13:20 New opportunities for EUFAS General assembly Novel neurobiology - informing clinical cannabis, cognition and practice and policy 13:20 to 14:50 craving development in the area of behavioural addictions Auditorium II 13:20 to 14:50 13:20 to 14:50 PLENARY SESSION Auditorium III Auditorium I ORAL PRESENTATION SESSION MAJOR SESSION Understanding drug- Conceptual frameworks Young people, mental related deaths for studying drug policy health and substance use 13:20 to 14:50 13:20 to 14:50 13:20 to 14:50 Auditorium IV Auditorium VI Auditorium VII ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION SESSION Nitazene-related fatal Public health and safety Pregnancy, drug use and and non-fatal toxicity in impacts of cannabis care Europe: hospital legalization in Canada: emergency perspective five years in review 13:20 to 14:50 13:20 to 14:50 13:20 to 14:50 Room 5B Auditorium VIII Room 5A ORAL PRESENTATION SESSION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION Co-creating robust Understanding harm European prevention systems with workers reduction: economic, curriculum: increasing social, and health the use of evidence- 13:20 to 14:50 perspectives based prevention Room 5C 13:20 to 14:50 13:20 to 14:50 ORAL PRESENTATION Room 1.05 Room 1.06 SESSION SHORT COMMUNICATION SHORT COMMUNICATION SESSION SESSION Women's realities of drug WAVE Cine Video contest Scenarios for the future use session 2: Sharing of addictions fields by insightful lived 2040 13:20 to 14:50 experience 13:20 to 14:50 Room 1.08 13:20 to 14:50 Room 1.10 ORAL PRESENTATION Room 1.09 SESSION WORKSHOP VIDEO CONTEST Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief 13:20 to 14:50 Room 1.15 WORKSHOP 14:50 Break 14:50 to 15:00 BREAK 15:00 New perspectives: AI as a Alcohol epidemiology: NPS: Pharmacological tool to support the social inequalities Characterization and addictions workforce Substance Analysis 15:00 to 16:30 15:00 to 16:30 15:00 to 16:30 Auditorium II Auditorium I Auditorium III ORAL PRESENTATION MAJOR SESSION SESSION ORAL PRESENTATION SESSION Hepatitis C testing and Cannabis legalisation — How can treatment be a treatment models and impacts better experience? 15:00 to 16:30 15:00 to 16:30 15:00 to 16:30 Auditorium IV Auditorium VI Auditorium VII ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION SESSION The hepatitis C endgame: Protective and risk Policy issues in gambling Science, Policy, Politics factors in drug prevention 15:00 to 16:30 15:00 to 16:30 15:00 to 16:30 Room 5B Auditorium VIII Room 5A ORAL PRESENTATION MAJOR SESSION SESSION ORAL PRESENTATION SESSION A unique care model for Novel psychoactive From genes to brains inpatient addictions and substances and latest tri-morbidity within an drug trends in Asia and 15:00 to 16:30 acute UK hospital Pacific countries Room 1.06 15:00 to 16:30 15:00 to 16:30 SHORT COMMUNICATION Room 5C Room 1.05 SESSION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION City insights: creating a Drug trends: experiences How to train an addiction collaborative network for from Brazil, the specialist? city-level monitoring of Netherlands, Portugal, drug trends and harm and Spain 15:00 to 16:30 reduction 15:00 to 16:30 Room 1.10 15:00 to 16:30 Room 1.08 WORKSHOP Room 1.07 ORAL PRESENTATION WORKSHOP SESSION How to respond to real- time drug alerts in European countries ? 15:00 to 16:30 Room 1.15 WORKSHOP 16:30 Coffee break 16:30 to 16:50 BREAK 16:50 How can the voices of Alcohol and gender Mixed methods for people with lived issues understanding drug use experience, clients and communities impacted by 16:50 to 18:20 16:50 to 18:20 drug use better inform clinical practice, research Auditorium II Auditorium III and the policy agenda? ORAL PRESENTATION ORAL PRESENTATION 16:50 to 17:50 SESSION SESSION Auditorium I BIG DEBATE Viral hepatitis among Alcohol use among the Substance use and people who inject drugs elderly mental health in treatment settings 16:50 to 18:20 16:50 to 18:20 16:50 to 18:20 Auditorium IV Auditorium VI Auditorium VII ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION ORAL PRESENTATION SESSION Misuse of medicines New research on alcohol Hospital-based and tobacco policy treatments 16:50 to 18:20 16:50 to 18:20 16:50 to 18:20 Auditorium VIII Room 5A Room 5B ORAL PRESENTATION SESSION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION From old to new: changes Behavioural addictions, Newly regulated markets, in drug use prevention and theory managing harms, treatment & advocating 16:50 to 18:20 16:50 to 18:20 for reform Room 5C Room 1.05 16:50 to 18:20 ORAL PRESENTATION SHORT COMMUNICATION Room 1.06 SESSION SESSION SHORT COMMUNICATION SESSION Internet, smartphones ScaleUp: Options for A two-phased and social media use scalable psychosocial and augmentation/interventio pharmacological n extension of 16:50 to 18:20 treatment of stimulant Claremont’s media-based use disorder prevention education Room 1.07 model 16:50 to 18:20 SHORT COMMUNICATION 16:50 to 18:20 SESSION Room 1.08 Room 1.10 ORAL PRESENTATION SESSION WORKSHOP Toolkit to Deal with Female Drug User Victims of Gender-Based Violence 16:50 to 18:20 Room 1.15 WORKSHOP 17:50 EUDA presentation 17:50 to 18:20 Auditorium I MAJOR SESSION 18:20 Break 18:20 to 18:30 BREAK 18:30 EUDA launch networking dinner (for all conference participants) 18:30 to 21:30 BREAK Fri 25 Oct 09:00 Joining the dots: the A comparative discussion e-poster session day 3 relationship between on the role, challenges, and opportunities for 09:00 to 14:50 substance use and addiction nurses within other health conditions Europe Digital kiosks Plenary session 3 09:00 to 10:30 E-POSTER SESSION 09:00 to 10:30 Room 1.15 Auditorium I WORKSHOP PLENARY SESSION e-short communication session day 3 09:00 to 14:50 Digital kiosks E-SHORT COMMUNICATION SESSION 10:30 Coffee break 10:30 to 10:50 BREAK 10:50 The ripple effect: Alcohol: interventions Gaming and social media International and up-to-date use developments in the technologies opioid market and their 10:50 to 12:20 potential implications for 10:50 to 12:20 European public health Auditorium III and security Auditorium II ORAL PRESENTATION 10:50 to 12:20 ORAL PRESENTATION SESSION SESSION Auditorium I MAJOR SESSION Intentional and non- Psychedelics 2 Trauma and substance intentional drug-related use deaths 10:50 to 12:20 10:50 to 12:20 10:50 to 12:20 Auditorium VI Auditorium VII Auditorium IV ORAL PRESENTATION SESSION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION Unravelling the nexus: Drugs checking services Online monitoring understanding drug- related violence across 10:50 to 12:20 10:50 to 12:20 Europe Room 5A Room 5B 10:50 to 12:20 ORAL PRESENTATION ORAL PRESENTATION Auditorium VIII SESSION SESSION ORAL PRESENTATION SESSION Substance use and Emerging challenges in Gaming and health treatment needs across drug markets: European prisons monitoring, 10:50 to 12:20 measurement & impacts 10:50 to 12:20 Room 1.06 10:50 to 12:20 Room 5C SHORT COMMUNICATION Room 1.05 SESSION ORAL PRESENTATION SESSION SHORT COMMUNICATION SESSION Support for the addiction How can cannabis policy WAVE Cine Video contest workforce goals inform the session 3: Journeys development of through addiction science 10:50 to 12:20 evaluation indicators? and lived experience Room 1.07 10:50 to 12:20 10:50 to 12:20 ORAL PRESENTATION Room 1.08 Room 1.09 SESSION WORKSHOP VIDEO CONTEST Closed session Intimate partner violence perpetration: The ECR Programme — EU ADVANCE-Digital research funding Programme for men opportunities 10:50 to 12:20 10:50 to 12:20 Room 1.15 Room 1.10 WORKSHOP WORKSHOP 12:20 Lunch break 12:20 to 13:20 BREAK 13:20 Findings from The Lancet Alcohol and other drug Young people and drugs Public Health Commission policies in the work on Gambling: protecting setting – a perspective on 13:20 to 14:50 the public from gambling European developments harms Auditorium III 13:20 to 14:50 13:20 to 14:50 ORAL PRESENTATION Auditorium II SESSION Auditorium I ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION Overdose prevention Addressing diverse Substance use and treatment needs mental health in prison 13:20 to 14:50 settings 13:20 to 14:50 Auditorium IV 13:20 to 14:50 Auditorium VI ORAL PRESENTATION Auditorium VII SESSION ORAL PRESENTATION SESSION ORAL PRESENTATION SESSION Regulating cannabis Prevention and addiction Impact of drug policy on supply policies in Europe: in underrepresented drug production & navigating the long road groups markets to change 13:20 to 14:50 13:20 to 14:50 13:20 to 14:50 Room 5A Room 5B Auditorium VIII ORAL PRESENTATION ORAL PRESENTATION ORAL PRESENTATION SESSION SESSION SESSION Holistic care for mental Future of opioid markets Research into practice: well-being in Europe: Foresight The implementation and approaches evaluation of alcohol 13:20 to 14:50 assertive outreach 13:20 to 14:50 treatment in England Room 1.05 Room 1.10 13:20 to 14:50 SHORT COMMUNICATION SESSION WORKSHOP Room 1.15 WORKSHOP 14:50 Break 14:50 to 15:00 BREAK 15:00 Future paradigms for drug markets and drug policies? Closing session 15:00 to 16:40 Auditorium I PLENARY SESSION 16:40 Closing ceremony 16:40 to 16:50 Auditorium I PLENARY SESSION Source URL:https://www.lisbonaddictions.eu/lisbon-addictions-2024/programme Proforma Invoice: 92132D48746_2091 Sotsiaalkindlustusamet Paldiski mnt 80 Tallinn Date: 04-10-2024 10617 Estonia 000000000 Lisbon Addictions 2024 Dear Sir/Madam Kelli Ilisson Services Name Quantity Date Price Status Registration - Regular fee €670,00 Pending Total EUR 670,00 The bank transfer must be made to the account number mentioned below, free of charge to the recipient: Payee: VIAGENS ABREU, SA VAT Number: 500297177 Bank: Banco BPI Bank Account: 6-1292463.000.001 IBAN: PT50 0010 0000 1292 4630 0013 1 Swift/BIC: BBPIPTPL In the bank transfer information enter the participant’s name and event and/or registration number. Your registration will be definitely confirmed after receiving the value in the above bank account. We recommend you to make the bank transfer as soon as possible. Please send a copy of the payment proof by email to the Executive Secretariat of the event: Email: [email protected] _______________________________________________________________________________________ VIAGENS ABREU, SA - SEDE: Prç da Trindade,142,4º 4000-539 PORTO - CRC DO PORTO E NIF 500297177 - CAPITAL SOCIAL: 7,500,000€ - RNAVT 1702
Allikas: Sotsiaalkindlustusamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel